文献速递血栓与止血

血友病A与非血友病个体CD4+ T细胞对凝血因子VIII相同表位产生应答

T cells from individuals with and without hemophilia A respond to the same epitopes in factor VIII.
PubMed 文献 · J Thromb Haemost · 2025-12-12

本研究采用干扰素-γ酶联免疫斑点(ELISPOT) assay 并加入共刺激,检测无血友病A供者未经 manipulat 的CD4+ T细胞及体外扩增的FVIII特异性CD4+ T细胞系,识别FVIII蛋白及合成15-mer FVIII肽的应答。结果显示,无血友病A供者T细胞可识别FVIII免疫优势表位,且部分HLA-DRB1限制性表位在携带相同HLA-DRB1等位基因的血友病A患者T细胞中可重复检出。结论提示,无血友病A供者中逃逸胸腺编辑的自身FVIII特异性CD4+ T细胞可响应与血友病A患者相同的表位,共刺激增强ELISPOT可用于健康供者血液鉴定临床相关T细胞表位,克服儿科患者血量限制。

要点

  • 无血友病A供者CD4+ T细胞可识别FVIII免疫优势表位。
  • 部分HLA-DRB1限制性表位在相同HLA-DRB1等位基因的血友病A患者中可重复检出。
  • 共刺激增强ELISPOT可用健康供者血液鉴定临床相关FVIII T细胞表位。

核心结论

  • 无血友病A个体中逃逸胸腺编辑的自身FVIII特异性CD4+ T细胞可响应血友病A患者识别的相同表位。
  • 共刺激增强ELISPOT assay 可利用无血友病A健康供者血液鉴定临床相关FVIII T细胞表位。

研究设计与样本

  • 采用干扰素-γ ELISPOT assay 并加入共刺激,检测无血友病A供者未经 manipulat 的CD4+ T细胞和体外扩增的FVIII特异性CD4+ T细胞系。
  • 同时测试对FVIII蛋白和合成15-mer FVIII肽的应答。

主要发现

  • 无血友病A供者未经 manipulat 和体外扩增的CD4+ T细胞群均识别FVIII免疫优势表位。
  • 体外扩增T细胞系方案产生较高背景干扰素-γ分泌,可能掩盖对某些FVIII表位的应答。
  • 使用无血友病A受试者T细胞鉴定的若干HLA-DRB1限制性表位,在携带相同HLA-DRB1等位基因的血友病A受试者T细胞中可重复检出。

临床怎么用

  • 共刺激增强ELISPOT assay 可利用健康供者血液鉴定FVIII临床相关T细胞表位,克服儿科患者血量限制。

局限性

  • 体外扩增T细胞系方案背景干扰素-γ分泌较高,可能掩盖部分FVIII表位应答。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Development of neutralizing anti-factor [F]VIII antibodies (inhibitors) follows recognition by CD4+ T cells of epitopes that are presented on the individual's human leukocyte antigen (HLA) class II. Limited blood volumes have presented a major challenge in mapping T-cell epitopes in FVIII, especially as these immune responses typically develop in early childhood. OBJECTIVES: To determine whether CD4+ T cells from individuals with and without hemophilia A (HA) respond to the same T-cell epitopes. METHODS: We used interferon-γ enzyme-linked immunospot (ELISPOT) assays with added costimulation to test both unmanipulated CD4+ T cells and in vitro-expanded FVIII-specific CD4+ T-cell lines from donors without HA, to identify responses to FVIII protein and to synthetic 15-mer FVIII peptides. RESULTS: Tests of both unmanipulated and in vitro-expanded CD4+ T-cell populations from donors without HA identified immunodominant epitopes in FVIII. However, the protocol using expanded T-cell lines produced higher background interferon-γ secretion, which could mask responses to some FVIII epitopes. Importantly, several HLA-DRB1-restricted epitopes identified using T cells from subjects without HA were reproducibly found using T cells from subjects with HA who carried the same HLA-DRB1 alleles. CONCLUSION: Circulating non-HA CD4+ T cells with self-FVIII specificity, i.e, cells that apparently escaped thymic editing, can respond to the same epitopes recognized by CD4+ T cells from individuals with HA. Therefore, costimulation-enhanced ELISPOT assays can identify clinically relevant T-cell epitopes in FVIII using blood from healthy donors without HA, thereby overcoming blood volume limitations inherent to pediatric patient populations.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Vir P, Karim AF, Gunasekera D, et al. T cells from individuals with and without hemophilia A respond to the same epitopes in factor VIII. J Thromb Haemost. 2025. PMID: 41391568. doi:10.1016/j.jtha.2025.11.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。